Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03207009 |
|---|---|
| Brief Title: | A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Subjects With Transfusion-Dependent β-Thalassemia |
| First Submitted : | June 29, 2017 |
| First Submitted that Met QC Criteria : | June 29, 2017 |
| First Posted : | July 2, 2017 |
| Last Update Submitted that Met QC Criteria : | June 23, 2021 |
| Last Update Posted : | June 24, 2021 (Estimate) |